Madani T A, Bormanis J
Department of Medicine, University of Ottawa, Ontario.
Can J Cardiol. 1997 Apr;13(4):391-4.
Two cases of severe hereditary hemochromatotic cardiomyopathy are reported. Both patients responded remarkably well to treatment and are leading a normal life requiring no cardiac medications, following small volume phlebotomies for two years combined, in the first three and six months of treatment, with subcutaneous deferoxamine mesylate.
报告了两例严重遗传性血色素沉着性心肌病病例。两名患者对治疗反应良好，在进行了两年的小容量静脉放血治疗，并在治疗的前三个月和六个月联合皮下注射甲磺酸去铁胺后，无需服用心脏药物，过着正常生活。
